FR167344 free base is an orally active, non-peptide bradykinin B2 receptor antagonist with high affinity for the B2 receptor (IC50 = 65 nM) and no affinity for the B1 receptor; it inhibits B2 receptor-mediated phosphatidylinositol hydrolysis and antagonizes bradykinin-induced responses; in vivo, it shows anti-inflammatory effects by inhibiting carrageenan-induced paw edema in rats (ID50 = 2.7 mg/kg), reduces kaolin-induced writhing in mice (ID50 = 2.8 mg/kg at 10 min; 4.2 mg/kg at 15 min), and attenuates caerulein-induced pancreatic edema (ID50 = 13.8 mg/kg) as well as elevated serum amylase (ID50 = 10.3 mg/kg) and lipase levels (ID50 = 7.4 mg/kg) in rats.